Loretta J Nastoupil Selected Research

Proteasome Endopeptidase Complex (Proteasome)

1/2022

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Loretta J Nastoupil Research Topics

Disease

32	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 12/2012
31	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 01/2020
24	Neoplasms (Cancer) 01/2024 - 09/2012
21	Lymphoma (Lymphomas) 04/2024 - 05/2015
17	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 09/2012
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 09/2013
5	Cytokine Release Syndrome 12/2023 - 12/2021
5	Hodgkin Disease (Hodgkin's Disease) 07/2020 - 01/2017
4	cell-associated neurotoxicity 10/2022 - 01/2020
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2024 - 10/2013
3	Exanthema (Rash) 11/2023 - 11/2015
3	Diarrhea 05/2022 - 01/2021
2	Cytopenia 01/2023 - 10/2021
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2022 - 01/2016
2	Neutropenia 05/2022 - 01/2018
2	Febrile Neutropenia 05/2022 - 10/2018
2	Cardiotoxicity 12/2021 - 10/2018
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020 - 01/2016
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 09/2013
1	Hepatitis B 04/2024
1	Inflammation (Inflammations) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 10/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2022
1	Infections 05/2022
1	Fatigue 05/2022
1	Nausea 01/2022
1	Pancreatitis 01/2022
1	Aseptic Meningitis 01/2022
1	Long Term Adverse Effects 10/2021
1	Opportunistic Infections (Opportunistic Infection) 10/2021
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2021
1	Colitis 01/2021

Drug/Important Bio-Agent (IBA)

27	Rituximab (Mabthera)FDA Link 11/2023 - 10/2012
26	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2020
15	axicabtagene ciloleucelIBA 11/2023 - 01/2020
8	Lenalidomide (CC 5013)FDA Link 11/2023 - 05/2015
7	Prednisone (Sone)FDA LinkGeneric 11/2023 - 07/2013
6	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 07/2013
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 07/2013
6	Vincristine (Oncovin)FDA LinkGeneric 11/2023 - 07/2013
4	tisagenlecleucelIBA 01/2024 - 01/2022
4	ibrutinibIBA 11/2023 - 02/2019
3	Alkylating AgentsIBA 11/2023 - 09/2013
3	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2022
3	Monoclonal AntibodiesIBA 01/2023 - 09/2013
3	fludarabineIBA 01/2023 - 05/2015
3	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2020
2	Bispecific AntibodiesIBA 03/2024 - 01/2024
2	Bendamustine Hydrochloride FDA Link 11/2023 - 11/2016
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2023 - 01/2020
2	InterferonsIBA 01/2023 - 01/2017
2	EnzymesIBA 01/2022 - 01/2021
2	pembrolizumabIBA 01/2022 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 10/2021
2	carboxyl radical (COO-)IBA 01/2021 - 01/2021
2	purineIBA 10/2018 - 09/2013
2	AntibodiesIBA 01/2017 - 07/2015
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2017 - 11/2016
1	AnthracyclinesIBA 04/2024
1	brexucabtagene autoleucelIBA 01/2024
1	Interleukin-15 (Interleukin 15)IBA 01/2024
1	Biological FactorsIBA 01/2024
1	serum P-component (CIt)IBA 11/2023
1	Small Cytoplasmic RNAIBA 11/2023
1	Circulating Tumor DNAIBA 11/2023
1	tafasitamabIBA 09/2023
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2023
1	Peptidoglycan (Murein)IBA 01/2023
1	CytokinesIBA 01/2023
1	Histone-Lysine N-MethyltransferaseIBA 01/2023
1	Histone MethyltransferasesIBA 01/2023
1	Thrombopoietin (c-mpl Ligand)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 05/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 05/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	PlatinumIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	UbiquitinIBA 01/2022
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 12/2021
1	copanlisibIBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2021

Therapy/Procedure

53	Therapeutics 12/2023 - 12/2012
18	Drug Therapy (Chemotherapy) 04/2024 - 09/2012
10	Radiotherapy 10/2021 - 07/2013
4	Immunotherapy 01/2023 - 07/2015
3	Combined Modality Therapy 01/2021 - 10/2019
2	Stem Cell Transplantation 01/2023 - 01/2018
2	Breast Implants (Breast Implant) 09/2022 - 01/2016
2	Radioimmunotherapy 03/2015 - 12/2012
1	Transplantation 10/2022
1	Autologous Transplantation 01/2021